Hepatology International最新文献

筛选
英文 中文
Strengthening the stratification of autoimmune hepatitis: toward enhanced clinical applicability. 加强自身免疫性肝炎的分层:提高临床适用性。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-02-04 DOI: 10.1007/s12072-026-11039-x
Yingting Zhu, Zirui Weng, Lin Miao
{"title":"Strengthening the stratification of autoimmune hepatitis: toward enhanced clinical applicability.","authors":"Yingting Zhu, Zirui Weng, Lin Miao","doi":"10.1007/s12072-026-11039-x","DOIUrl":"10.1007/s12072-026-11039-x","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1531-1532"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146118744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to letter to editor-Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. 对编辑的回复:使用聚乙二醇化干扰素治疗的无活性携带者在第24周快速HBsAg血清清除的机器学习预测。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-03-14 DOI: 10.1007/s12072-026-11048-w
Jianxia Dong, Sujun Zheng, Xinyue Chen
{"title":"Response to letter to editor-Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon.","authors":"Jianxia Dong, Sujun Zheng, Xinyue Chen","doi":"10.1007/s12072-026-11048-w","DOIUrl":"10.1007/s12072-026-11048-w","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1539-1540"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147456754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suppression of macrophage membrane cholesterol efflux by SLAMF7-induced IL-7 signaling improves immunotherapy efficacy in hepatocellular carcinoma. 通过slamf7诱导的IL-7信号抑制巨噬细胞膜胆固醇外排可提高肝癌的免疫治疗效果。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-06-09 DOI: 10.1007/s12072-026-11111-6
Jialei Weng, Fu Wang, Wenxin Xu, Liqian Zhao, Yushun Chang, Haowen Lu, Kai Xu, Heming Zheng, Yifan Wang, Xiujun Cai
{"title":"Suppression of macrophage membrane cholesterol efflux by SLAMF7-induced IL-7 signaling improves immunotherapy efficacy in hepatocellular carcinoma.","authors":"Jialei Weng, Fu Wang, Wenxin Xu, Liqian Zhao, Yushun Chang, Haowen Lu, Kai Xu, Heming Zheng, Yifan Wang, Xiujun Cai","doi":"10.1007/s12072-026-11111-6","DOIUrl":"10.1007/s12072-026-11111-6","url":null,"abstract":"<p><strong>Background: </strong>The limited efficacy of immunotherapy in hepatocellular carcinoma (HCC) is largely attributed to the formation of an immunosuppressive tumor microenvironment, in which abnormal cholesterol metabolism plays an important role. Here, we investigated the effects of signaling lymphocytic activation molecule family member 7 (SLAMF7) on the cholesterol metabolism of HCC.</p><p><strong>Methods: </strong>Metabolomics was performed in spontaneous HCC tissues with hepatocyte-specific Slamf7 knockout. An in vitro coculture system was constructed, and cytokine matrix, protein profiling, and transcriptome sequencing were applied to explore the function of SLAMF7 in HCC.</p><p><strong>Results: </strong>Profiling of the metabolomics of spontaneous HCC with Slamf7 knockout and the proteomics of SLAMF7-overexpressing HCC cells clarified the inhibition of cholesterol synthesis by SLAMF7 in HCC cells. Furthermore, HCC cell-intrinsic SLAMF7 inhibited membrane cholesterol efflux and function reprogramming in macrophages. Mechanistically, SLAMF7 interacted with DHCR24 and enhanced the binding and ubiquitination degradation of DHCR24 by MARCH6 via its intracellular domain to inhibit cholesterol synthesis in HCC cells. Reduction of cholesterol content in lipid rafts impaired the AKT activation and promoted entry of dephosphorylated FOXO1 into nucleus for IL-7 transcription. Subsequently, IL-7 reduced membrane cholesterol efflux by inhibiting the NF-κB pathway and ABCA1 transcription in macrophages. Pharmacological enhancement of IL-7 signaling improved the efficacy of anti-PD-1 antibody in HCC mouse models with low SLAMF7 level.</p><p><strong>Conclusions: </strong>Our study molecularly identifies a key role of SLAMF7 in cholesterol metabolism and trafficking between HCC cells and macrophages and gives a rationale for targeting IL-7 signaling as an effective strategy to sensitize HCC to immunotherapy.</p>","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1479-1496"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148204575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Untapped potential of efruxifermin in lean MASH. fruxifermin在瘦肉型MASH中尚未开发的潜力。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2025-12-01 DOI: 10.1007/s12072-025-10981-6
Mohammadjavad Sotoudeheian
{"title":"Untapped potential of efruxifermin in lean MASH.","authors":"Mohammadjavad Sotoudeheian","doi":"10.1007/s12072-025-10981-6","DOIUrl":"10.1007/s12072-025-10981-6","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1510-1511"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145648331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to: A commentary on "Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis". 回复:关于“替诺福韦阿拉那胺在高脂血症和心血管疾病中的安全性:一项全国性分析”的评论。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2025-10-25 DOI: 10.1007/s12072-025-10941-0
Jae-Young Kim, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
{"title":"Reply to: A commentary on \"Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis\".","authors":"Jae-Young Kim, Hyuk Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim","doi":"10.1007/s12072-025-10941-0","DOIUrl":"10.1007/s12072-025-10941-0","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1497-1498"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145367922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on early prediction of HBsAg seroclearance using machine learning in inactive carriers. 机器学习在非活性携带者中早期预测HBsAg血清清除率的研究进展。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-02-27 DOI: 10.1007/s12072-026-11063-x
Zhuo Liu, Zhihui Xu, Nan Wang
{"title":"Commentary on early prediction of HBsAg seroclearance using machine learning in inactive carriers.","authors":"Zhuo Liu, Zhihui Xu, Nan Wang","doi":"10.1007/s12072-026-11063-x","DOIUrl":"10.1007/s12072-026-11063-x","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1537-1538"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147305049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on recurrence patterns in HCC with microvascular invasion. 肝细胞癌伴微血管侵犯复发模式的探讨。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2025-12-22 DOI: 10.1007/s12072-025-10993-2
Xingxing Yao, Enhui Lv, Kequn Chai
{"title":"Comments on recurrence patterns in HCC with microvascular invasion.","authors":"Xingxing Yao, Enhui Lv, Kequn Chai","doi":"10.1007/s12072-025-10993-2","DOIUrl":"10.1007/s12072-025-10993-2","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1512-1513"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Converging pathways: the interaction between estimated glucose disposal rate and atherogenic index of plasma in MASLD risk stratification. 收敛路径:MASLD风险分层中估计葡萄糖处置率与血浆动脉粥样硬化指数的相互作用
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-05-25 DOI: 10.1007/s12072-026-11098-0
Mingxing Chang, Peipu Shen, Guifang Shen
{"title":"Converging pathways: the interaction between estimated glucose disposal rate and atherogenic index of plasma in MASLD risk stratification.","authors":"Mingxing Chang, Peipu Shen, Guifang Shen","doi":"10.1007/s12072-026-11098-0","DOIUrl":"10.1007/s12072-026-11098-0","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global health burden linked to insulin resistance and atherogenic dyslipidemia, estimated by the glucose disposal rate (eGDR) and atherogenic index of plasma (AIP), respectively. However, the nature of their combined association-whether additive or interactive-with MASLD risk, and its utility for risk stratification, remains unexplored.</p><p><strong>Methods: </strong>In this large-scale cross-sectional analysis of 30,143 adults, we calculated eGDR and AIP from routine clinical measures. Their independent and joint associations with ultrasonography-defined MASLD were assessed using multivariable logistic regression, restricted cubic splines (RCS), and interaction analysis. Based on RCS-derived thresholds, participants were categorized into four metabolic phenotypes for combined risk assessment.</p><p><strong>Results: </strong>Both lower eGDR and higher AIP were independently and nonlinearly associated with greater MASLD risk (p for trend < 0.001). A significant interaction was observed (p < 0.001), revealing a convergent pattern: the protective association of high eGDR appeared attenuated as AIP increased, and the risk disparity attributable to AIP narrowed markedly at low eGDR levels. Participants with the combined low-eGDR/high-AIP phenotype had the highest MASLD odds (OR = 3.42, 95% CI 3.07-3.81). These findings were robust to alternative adjustment strategies and phenotype definitions in sensitivity analyses.</p><p><strong>Conclusions: </strong>eGDR and AIP exhibit a significant interactive association with MASLD risk, characterized by a convergent pattern: the incremental risk associated with atherogenic dyslipidemia (high AIP) appeared less pronounced under conditions of severe insulin resistance (low eGDR). Integrating these two metrics identifies a distinct high-risk phenotype and may inform future risk stratification strategies. Longitudinal studies are needed to establish causality and clinical utility.</p>","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1340-1352"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13676677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148015191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol and dementia: is hepatic steatosis an innocent bystander or an active contributor to cognitive decline? 酒精和痴呆:肝脂肪变性是认知能力下降的无辜旁观者还是积极贡献者?
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-09-09 DOI: 10.1007/s12072-026-11149-6
Cameron Gofton, Elie Matar, Jacob George
{"title":"Alcohol and dementia: is hepatic steatosis an innocent bystander or an active contributor to cognitive decline?","authors":"Cameron Gofton, Elie Matar, Jacob George","doi":"10.1007/s12072-026-11149-6","DOIUrl":"10.1007/s12072-026-11149-6","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1295-1298"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13676623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148919199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to: "Refining Surgical Indications for Hepatocellular Carcinoma in Patients with Clinically Significant Portal Hypertension". 回应:“改进肝细胞癌临床显著门脉高压患者的手术指征”。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2025-11-28 DOI: 10.1007/s12072-025-10960-x
Yukihiro Watanabe, Masayasu Aikawa, Yoshiki Murase, Kenichiro Takase, Yuichiro Watanabe, Hiroaki Ono, Katsuya Okada, Kojun Okamoto, Isamu Koyama
{"title":"Response to: \"Refining Surgical Indications for Hepatocellular Carcinoma in Patients with Clinically Significant Portal Hypertension\".","authors":"Yukihiro Watanabe, Masayasu Aikawa, Yoshiki Murase, Kenichiro Takase, Yuichiro Watanabe, Hiroaki Ono, Katsuya Okada, Kojun Okamoto, Isamu Koyama","doi":"10.1007/s12072-025-10960-x","DOIUrl":"10.1007/s12072-025-10960-x","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1506-1507"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145632650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书